DE20306600U1 - Pharmaceutical product, useful for skin or wound care, comprises an ointment base containing a tincture of poplar bud resin combined with milk fat or another carrier - Google Patents

Pharmaceutical product, useful for skin or wound care, comprises an ointment base containing a tincture of poplar bud resin combined with milk fat or another carrier

Info

Publication number
DE20306600U1
DE20306600U1 DE20306600U DE20306600U DE20306600U1 DE 20306600 U1 DE20306600 U1 DE 20306600U1 DE 20306600 U DE20306600 U DE 20306600U DE 20306600 U DE20306600 U DE 20306600U DE 20306600 U1 DE20306600 U1 DE 20306600U1
Authority
DE
Germany
Prior art keywords
tincture
ointment base
wound care
skin
care product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE20306600U
Other languages
German (de)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KARPFL PETER
KARPFL VERA
Original Assignee
KARPFL PETER
KARPFL VERA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KARPFL PETER, KARPFL VERA filed Critical KARPFL PETER
Priority to DE20306600U priority Critical patent/DE20306600U1/en
Publication of DE20306600U1 publication Critical patent/DE20306600U1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/76—Salicaceae (Willow family), e.g. poplar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0057—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Skin or wound care product comprises an ointment base comprising a tincture of poplar bud resin (8-10 g or 15 g) combined with milk fat or another carrier (100 g). ACTIVITY : Dermatological; Vulnerary. No biological data given. MECHANISM OF ACTION : None given.

Description

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßtThe description text was not recorded electronically

Claims (4)

1. Hautpflegeprodukt bzw. Wundpflegemittel, dadurch gekennzeichnet, dass Pappelknospenharz in seiner Verbindung mit Melkfett oder anderen Trägersubstanzen als Salbengrundlage, als Tinktur von 8-10 Gramm auf 100 Gramm einer Trägersubstanz eingebracht wird.1. Skin care product or wound care product, characterized in that poplar bud resin is introduced in its connection with milking fat or other carrier substances as an ointment base, as a tincture of 8-10 grams per 100 grams of a carrier substance. 2. Hautpflegeprodukt, bzw. Wundpflegemittel, nach Anspruch 1, dadurch gekennzeichnet, dass die Tinktur auch 15 Gramm enthalten kann.2. Skin care product or wound care product according to claim 1, characterized characterized that the tincture can also contain 15 grams. 3. Hautpflegeprodukt, bzw. Wundpflegemittel, nach Anspruch 1, dadurch gekennzeichnet, dass das Granulat nach der Herstellung der Tinktur als Restbestand nach Abseihen zu 8-10 Gramm in Melkfett oder einer anderen Trägersubstanz als Salbengrundlage, eingebracht werden kann.3. Skin care product or wound care product according to claim 1, characterized characterized that the granules after the manufacture of the tincture as a residual stock after straining to 8-10 grams in milking fat or a carrier other than Ointment base, can be introduced. 4. Hautpflegeprodukt bzw. Wundpflegemittel, nach Anspruch 1, dadurch gekennzeichnet, dass das Granulat nach der Herstellung der Tinktur als Restbestand nach Abseihen zu 15 Gramm in Melkfett oder einer anderen Trägersubstanz als Salbengrundlage, eingebracht werden kann.4. Skin care product or wound care product according to claim 1, characterized characterized that the granules after the manufacture of the tincture as a residual stock after straining to 15 grams in milking fat or another carrier than Ointment base, can be introduced.
DE20306600U 2003-04-29 2003-04-29 Pharmaceutical product, useful for skin or wound care, comprises an ointment base containing a tincture of poplar bud resin combined with milk fat or another carrier Expired - Lifetime DE20306600U1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE20306600U DE20306600U1 (en) 2003-04-29 2003-04-29 Pharmaceutical product, useful for skin or wound care, comprises an ointment base containing a tincture of poplar bud resin combined with milk fat or another carrier

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE20306600U DE20306600U1 (en) 2003-04-29 2003-04-29 Pharmaceutical product, useful for skin or wound care, comprises an ointment base containing a tincture of poplar bud resin combined with milk fat or another carrier

Publications (1)

Publication Number Publication Date
DE20306600U1 true DE20306600U1 (en) 2003-09-04

Family

ID=27816367

Family Applications (1)

Application Number Title Priority Date Filing Date
DE20306600U Expired - Lifetime DE20306600U1 (en) 2003-04-29 2003-04-29 Pharmaceutical product, useful for skin or wound care, comprises an ointment base containing a tincture of poplar bud resin combined with milk fat or another carrier

Country Status (1)

Country Link
DE (1) DE20306600U1 (en)

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2594336A1 (en) * 1985-09-03 1987-08-21 Brevier Christiane Propolis: purified natural substance employed in agri-foodstuffs, agriculture, cosmetics, dermatology and hygiene products
JPS63179812A (en) * 1987-01-22 1988-07-23 Shiseido Co Ltd External preparation for skin
DE69214732T2 (en) * 1991-07-03 1997-05-15 Lhd Lab Hygiene Dietetique Healing wound dressing
JPH09208478A (en) * 1996-02-06 1997-08-12 Kazunori Murakami Propolis preparation utilizing centrifugal separation method
DE19615293A1 (en) * 1996-04-18 1997-10-23 Johann Dibart Propolis skin disorder salve
JPH10215815A (en) * 1997-02-03 1998-08-18 Shiyaburon:Kk Propolis-containing cellulose
DE69228966T2 (en) * 1991-08-27 1999-12-02 Hayashibara Biochem Lab Process for producing a purified propolis extract and its uses
DE19904801A1 (en) * 1999-02-05 2000-08-10 Klossner Axel Agent containing urea, sulfur and Calendula extract, useful for topical treatment of skin disorders, especially neurodermatitis
DE69802545T2 (en) * 1997-08-11 2002-06-27 Andre Pierre Morice PROPOLIS AND AT LEAST ONE COMPOSITION CONTAINING ESSENTIAL OIL
DE69232338T2 (en) * 1991-02-15 2002-09-19 Fockerman Jasmine Benzopyranphenol derivatives for use as antibacterial, antiviral and wound healing agents
WO2002076411A2 (en) * 2001-03-27 2002-10-03 Dorian Owoc Dermatological agent for the treatment of skin trauma, especially in burn conditions
JP2003055138A (en) * 2001-08-08 2003-02-26 Kenji Nakamura Sheet cosmetic containing propolis

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2594336A1 (en) * 1985-09-03 1987-08-21 Brevier Christiane Propolis: purified natural substance employed in agri-foodstuffs, agriculture, cosmetics, dermatology and hygiene products
JPS63179812A (en) * 1987-01-22 1988-07-23 Shiseido Co Ltd External preparation for skin
DE69232338T2 (en) * 1991-02-15 2002-09-19 Fockerman Jasmine Benzopyranphenol derivatives for use as antibacterial, antiviral and wound healing agents
DE69214732T2 (en) * 1991-07-03 1997-05-15 Lhd Lab Hygiene Dietetique Healing wound dressing
DE69228966T2 (en) * 1991-08-27 1999-12-02 Hayashibara Biochem Lab Process for producing a purified propolis extract and its uses
JPH09208478A (en) * 1996-02-06 1997-08-12 Kazunori Murakami Propolis preparation utilizing centrifugal separation method
DE19615293A1 (en) * 1996-04-18 1997-10-23 Johann Dibart Propolis skin disorder salve
JPH10215815A (en) * 1997-02-03 1998-08-18 Shiyaburon:Kk Propolis-containing cellulose
DE69802545T2 (en) * 1997-08-11 2002-06-27 Andre Pierre Morice PROPOLIS AND AT LEAST ONE COMPOSITION CONTAINING ESSENTIAL OIL
DE19904801A1 (en) * 1999-02-05 2000-08-10 Klossner Axel Agent containing urea, sulfur and Calendula extract, useful for topical treatment of skin disorders, especially neurodermatitis
WO2002076411A2 (en) * 2001-03-27 2002-10-03 Dorian Owoc Dermatological agent for the treatment of skin trauma, especially in burn conditions
JP2003055138A (en) * 2001-08-08 2003-02-26 Kenji Nakamura Sheet cosmetic containing propolis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DAZ - Deutsche Apitherapie Zeitung, 3. Juli-Sept. 2001, S.6-11 *
http://gb.onlinehost.de/g/gb.pl?show&user=pferde&eNr.68 Marion (Internet recherchiert am 28.07.2003) *

Similar Documents

Publication Publication Date Title
ATE214287T1 (en) USE OF RELAXIN FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF CARDIOVASCULAR DISEASES.
HU9200249D0 (en) Veterinary product with delayed active agent activity
DE20306600U1 (en) Pharmaceutical product, useful for skin or wound care, comprises an ointment base containing a tincture of poplar bud resin combined with milk fat or another carrier
Choudhury Association between electrocardiographic ischemic abnormaties and ischemic heart disease risk factors in a Japanese population.
Wikblad Care and self-care in diabetes: A study in patients with onset of diabetes before 1975.
Orth-Gomer Individual and environmental resources for health promotion: Interactive effects.
Elefson et al. 75 Assessment of allometric changes of visceral organs in pigs from birth to 10 kg bodyweight at 14 days post-weaning
Dawson et al. 23 Effects of Rubber Matting on Cattle Locomotion Scores in Slatted Facilities
Lacayo et al. After the revolution.
Higginbottom ON THE USE OF THE NITRATE OF SILVER IN ERYSIPELAS.
Ferguson Speaking for the American People...
Agyekum et al. 311 Dietary D-xylose effects on growth performance and portal-drained viscera nutrient fluxes, insulin production, and oxygen consumption in growing pigs
AT211960B (en) Skin, hair and nail care and growth preparations
Belchetz Heavy mettle
Rankin SPECIFIC PHYSIOLOGICAL RESPONSES OF ELITE RUNNERS: 100 M-10,000 M.
Glávits et al. Nephropathy caused by ochratoxin-A in a Hungarian swine stock
Garrod Animal Infections
Fletcher Lung Function
Wood Modern Cardiology
Ferreira Characterization of the antagonistic interaction between fluazifop and DPX-PE350.
Kopchekchi et al. Use of phito preparations for acupuncture impact at purulent-catarrhal mastitis in cows
Briant CARDIOVASCULAR RESPONSE TO VARIABLE RATE AND PARTIAL VOLUME DECOMPRESSION OF LARGE AND SMALL BLADDER VOLUMES OF THE ACUTELY DISTENDED DOG BLADDER (PATIENT CARE, HUMAN)
Greene American Physiological Society
Edition et al. Union Medical College.
DE1916006U (en) FOOTPADS.

Legal Events

Date Code Title Description
R086 Non-binding declaration of licensing interest
R163 Identified publications notified
R207 Utility model specification

Effective date: 20031009

R156 Lapse of ip right after 3 years

Effective date: 20061101